Alector announces appointment of gary romano, m.d., ph.d., as chief medical officer

South san francisco, calif., march 29, 2022 (globe newswire) -- alector, inc. (nasdaq: alec), a clinical-stage biotechnology company pioneering immuno-neurology, today announced the appointment of gary romano, m.d., ph.d., as chief medical officer. in this role, dr. romano will lead the company's global clinical development strategy, including oversight of the clinical development, clinical operations, biometrics and digital science, and medical affairs functions. dr. romano will report to sara kenkare-mitra, ph.d., president and head of research and development of alector. dr. romano's appointment is effective may 23, 2022.
ALEC Ratings Summary
ALEC Quant Ranking